-
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Bakker, N. A. M., Garner, H., van Dyk, E., Champanhet, E., Klaver, C., Duijst, M., Voorwerk, L., Nederlof, I., Voorthuis, R., Liefaard, M. C., Nieuwland, M., de Rink, I., Bleijerveld, O. B., Oosterkamp, H. M., Wessels, L. F. A., Kok, M. & de Visser, K. E., 1 Dec 2025, In: npj Breast Cancer. 11, 1, 5.Research output: Contribution to journal › Article* › Academic › peer-review
-
Immune infiltration and activation in breast tumors
Nederlof, I., 2025, 321 p.Research output: PhD thesis › Thesis, fully internal
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
Nederlof, I., Isaeva, O. I., de Graaf, M., Gielen, R. C. A. M., Bakker, N. A. M., Rolfes, A. L., Garner, H., Boeckx, B., Traets, J. J. H., Mandjes, I. A. M., de Maaker, M., van Brussel, T., Chelushkin, M., Champanhet, E., Lopez-Yurda, M., van de Vijver, K., van den Berg, J. G., Hofland, I., Klioueva, N. & Mann, R. M. & 18 others, , Nov 2024, In: Nature Medicine. 30, 11, p. 3223-3235 13 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
